glp-1 gastric stasis law firm in louisiana semaglutide west virginia Gastrointestinal Motility Effects of Receptor Agonists glp-1 gastric intestinal obstruction law

Scott Butsch, MD, explains why its not a recommended practice

2024;44(11):NP809-NP818

Adoption remained modest until recent years as GLP-1 drug claims rose from 6.9 percent in 2023 to 10.5 percent in 2025

The appetite-suppressing effects of semaglutide GLP-1 usually become noticeable within a few weeks, after initiating the treatment, and it doesnt take long for individuals to begin noticing weight loss

The key difference is manufacturing source: compounded versions are prepared by specialized pharmacies under strict USP standards rather than mass-manufactured by pharmaceutical corporations

The first step is to schedule your initial assessment with our New Orleans team and discover how we can help you succeed in 2026